Building an AI-driven multiomics aging drug platform to decode aging cell by cell
AgeCurve is building advanced aging diagnostics and therapeutics tools by combining somatic genotype with cellular phenotype on the single cell level and applying a full machine learning and AI stack.
Please see our study publiched in Geroscience: Cell Tree Rings: the structure of somatic evolution as a human aging timer
View studyAttila Csordas, PhD
CEO/Founder
Petr Sramek
Investor
Matthew Clevely
Business
Issac Emmanuel Kai'en Goh, PhD
Science, AI
Karoly Nikolich, PhD
Strategy
Fiona Nielsen
Business
Allart Stoop, PhD
Immunology
Professor Damien G. Hicks
Science